Class IIITerminatedF-0463-2024
Supplement recall · November 29, 2023
ACTIRON Dietary Supplement recall
Why: FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
- Lots / codes
Lot 13309, Exp: 01/26
- Quantity
- 607 bottles of 100 tablets each
- Company
- ActiPharma, Inc., Guaynabo, PR
- Distribution
- Domestic distribution, in Puerto Rico.
- Initiated
- September 28, 2023 · Voluntary: Firm initiated
- Classified
- November 17, 2023
- Reported
- November 29, 2023
- Ended
- January 16, 2024
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.